Wesley Yu, M.D.
- Associate Professor of Dermatology, School of Medicine
- Director, Melanoma and Skin Cancer Program, OHSU Knight Cancer Institute, School of Medicine
Biography
Dr. Wesley Yu specializes in treating skin cancers like basal cell carcinoma, squamous cell carcinoma, and melanoma with Mohs micrographic surgery (a specialized technique with the highest cure rate and best cosmetic outcome for skin cancers on the face or other sensitive areas). He has advanced training in reconstruction and is recognized as an expert in this area. Dr. Wesley Yu is double board certified in Dermatology and Mohs micrographic surgery.
Additionally, Dr. Yu serves as the Director for the Melanoma and Skin Cancer Program at Knight Cancer Institute. He leads multiple research projects investigating new treatments for high-risk skin cancers and melanoma that informs his clinical practice and allows him to recommend the most up to date treatments for his patients.
In his spare time, Dr. Yu enjoys playing tennis, listening to music, chasing his kid around, hiking and learning about the local area from his patients.
Education and training
-
Degrees
- M.D., 2015, University of California San Francisco
-
Residency
- Dermatology, University of California San Francisco
-
Fellowship
- Mohs Micrographic Surgery and Dermatologic Oncology, Case Western Reserve University and University Hospitals Cleveland
-
Certifications
- American Board of Dermatology, Dermatology
- American Board of Dermatology, Mohs micrographic surgery
Memberships and associations:
- Diplomate, American Board of Dermatology
- Member, American Academy of Dermatology
- Member, American Society for Dermatologic Surgery
- Member, Association of Professors of Dermatology
- Member, American College of Mohs Surgery
Additional information
Publications
Elsevier pure profilePublications
Accelerated Takedown of Melolabial Interpolation Flaps at 1 to 2 Weeks, Indications and Safety for Improved Patient Experience
Dermatologic SurgeryDevelopment of a treatment decision aid for patients with dysplastic nevi who are candidates for re-excision
Journal of the American Academy of DermatologyEnhanced Risk Stratification for Sentinel Lymph Node Biopsy in Head and Neck Melanoma Using the Merlin Assay (CP-GEP)
Annals of surgical oncologyReconstructive Conundrum
Dermatologic SurgeryEstablishing Consensus for Mohs Micrographic Surgical Techniques in the Treatment of Melanoma in Situ for Future Clinical Trials
JNCCN Journal of the National Comprehensive Cancer NetworkInvestigating visual preferences of clinical mechanical anesthetic vibration
Archives of Dermatological ResearchA Clinical Decision Tool to Calculate Pretest Probability of Sentinel Lymph Node Metastasis in Primary Cutaneous Melanoma
Annals of surgical oncologyExternal validation of the Melanoma Institute Australia Sentinel Node Metastasis Risk Prediction Tool using the National Cancer Database
Journal of the American Academy of DermatologyMinority enrollment in melanoma clinical trials
Journal of the American Academy of DermatologyRepair of a Lower Eyelid Defect
Dermatologic SurgeryTranexamic Acid Prevention of Hemorrhagic Complications Following Interpolated Flap Repair
Dermatologic SurgeryA Novel Potential Role for Monocytes Revealed by Single Cell Analysis of Immunotherapy Induced Immune Related Adverse Events
CancersMohs micrographic surgery of penile squamous cell carcinoma in situ with urethral extension
Archives of Dermatological ResearchRepair of a combined nose, cheek, and glabellar defect
Dermatologic SurgeryStatin use is associated with improved overall survival in patients with melanoma
Melanoma ResearchComputational Drug Repositioning Identifies Statins as Modifiers of Prognostic Genetic Expression Signatures and Metastatic Behavior in Melanoma
Journal of Investigative DermatologyEffect of Topical Brimonidine on Alcohol-Induced Flushing in Asian Individuals
JAMA DermatologyValidation of the English Basal and Squamous Cell Carcinoma Quality of Life (BaSQoL) Questionnaire
Dermatologic SurgeryCranial neuropathies as the presenting symptom of cutaneous squamous cell carcinoma
JAAD Case ReportsExpression of programmed cell death ligand 1 and programmed cell death 1 in cutaneous warts
Journal of the American Academy of DermatologyMohs Surgery for Advanced Tumors of the Scalp
Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]Outcomes and Risk Factors in Patients with Multiple Primary Melanomas
Journal of Investigative DermatologyWong-type dermatomyositis during anti–PD-1 therapy
JAAD Case Reports